Press Release July 10, 2021Rosen, Global Investor Counsel, Encourages Provention Bio, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important July 20 Deadline in Securities Class Action - PRVB 0 0 Share
Press Release July 10, 2021PRVB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 20, 2021 in the Class Action Filed on Behalf of Provention Bio, Inc. Limited Shareholders 0 0 Share
Press Release July 8, 2021PRVB LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Provention Bio, Inc. 0 0 Share
Press Release July 7, 2021SHAREHOLDER ALERT: Investigation of Provention Bio Announced by Holzer & Holzer, LLC 0 0 Share
Press Release July 7, 2021SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Provention Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 20, 2021 - PRVB 0 0 Share
Press Release July 6, 2021Provention Bio Receives Complete Response Letter (CRL) to Biologics License Application (BLA) for Teplizumab for the Delay of Clinical Type 1 Diabetes (T1D) in At-risk Individuals 0 0 Share
Company Ticker News July 6, 2021Provention Bio's Teplizumab Application Receives CRL For Type-1 Diabetes; Stock Drops 0 0 Share
Press Release July 6, 2021SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Provention Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 20, 2021 - PRVB 0 0 Share
Press Release July 6, 2021PRVB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 20, 2021 in the Class Action Filed on Behalf of Provention Bio, Inc. Limited Shareholders 0 0 Share
